Phase II studies of combinations of drugs with high dose carboplatin in neuroblastoma (800 mg/m2 to 1 g 250/m2): a report from the LMCE group

Prog Clin Biol Res. 1988:271:573-82.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carboplatin
  • Carmustine / therapeutic use
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Etoposide / therapeutic use*
  • Humans
  • Methoxyhydroxyphenylglycol / cerebrospinal fluid
  • Neuroblastoma / drug therapy*
  • Organoplatinum Compounds / therapeutic use*
  • Organoplatinum Compounds / toxicity

Substances

  • Organoplatinum Compounds
  • Methoxyhydroxyphenylglycol
  • Etoposide
  • Carboplatin
  • Carmustine